Pricing Log in Create free account

BioNTech SE Sponsored ADR (BNTX) vs Insmed, Inc. (INSM)

BioNTech SE Sponsored ADR and Insmed, Inc. are both Biotechnology companies. BioNTech SE Sponsored ADR and Insmed, Inc. are of similar size ($22.7B and $21.7B). Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against −3.33%. BioNTech SE Sponsored ADR has the higher net margin (−65.8% vs −76.9%) and the higher return on invested capital (−38.4% vs −329.2%). Across the 18 metrics below, BioNTech SE Sponsored ADR leads on 12 and Insmed, Inc. on 6.

Valuation

Metric BNTX INSM Biotechnology median
P/E n/m n/m 8.50
P/S 7.35 18.39 9.71
P/B 1.07 27.62 2.13
Price to free cash flow 44.31 n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.78 18.06 9.21
Earnings yield (8.94%) (4.27%) (33.15%)
Free cash flow yield 2.26% (3.86%) (25.50%)

Profitability

Metric BNTX INSM Biotechnology median
Gross margin 75.24% 83.46% 65.16%
Operating margin (77.94%) (73.89%) 0.00%
Net margin (65.75%) (76.94%) 0.00%
Free cash flow margin 16.58% (71.00%) 0.00%
Return on equity (9.53%) (87.22%) (56.36%)
Return on assets (8.24%) (38.20%) (48.04%)
Return on invested capital (38.39%) (329.22%) 0.00%

Growth

Metric BNTX INSM Biotechnology median
Revenue growth (TTM) (3.33%) 185.76% 6.02%
EPS growth (last fiscal year) (77.33%) (15.26%) 30.26%
Revenue growth, 5-year CAGR 42.58% 29.83% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTX INSM Biotechnology median
Debt to equity 0.02 0.74 0.00
Current ratio 7.85 3.72 4.72
Net debt to EBITDA 14.29 0.71 0.96

Dividend

Metric BNTX INSM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BNTX INSM Biotechnology median
Market cap 22.66b 21.67b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack